![](/images/graphics-bg.png)
Systemic Treatment of Vitreous Inflammation
Joint Authors
Christoforidis, John
Chang, Susie
Cebulla, Colleen M.
Jiang, Angela
Wang, Jillian
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-09-16
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Non infectious vitreous inflammation is often vision threatening and can be associated with potentially life-threatening systemic conditions.
Treatment is often challenging as it involves systemic medications that can be associated with adverse effects.
The classes of drugs are ever expanding and include corticosteroids, antimetabolites, alkylating agents, T-cell and calcineurin agents, biologic agents, and interferons.
Each class of systemic therapy for non-infectious vitreous inflammation is reviewed.
We discuss the mechanisms of action, usual clinical dosages, the specific conditions that are treated, the adverse effects, and usual course of treatment for each class of therapy.
American Psychological Association (APA)
Christoforidis, John& Chang, Susie& Jiang, Angela& Wang, Jillian& Cebulla, Colleen M.. 2012. Systemic Treatment of Vitreous Inflammation. Mediators of Inflammation،Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-1029455
Modern Language Association (MLA)
Christoforidis, John…[et al.]. Systemic Treatment of Vitreous Inflammation. Mediators of Inflammation No. 2012 (2012), pp.1-10.
https://search.emarefa.net/detail/BIM-1029455
American Medical Association (AMA)
Christoforidis, John& Chang, Susie& Jiang, Angela& Wang, Jillian& Cebulla, Colleen M.. Systemic Treatment of Vitreous Inflammation. Mediators of Inflammation. 2012. Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-1029455
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1029455